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that AEV replicates and induces the expres-
sion of p75 in macrophages, and that MC29
replicates and is expressed in erythroblasts
(Graf et al., in press).
These results are compatible with the
following model of DLV-induced leukaemo-
genesis and target-cell specificity (Graf &
Beug, 1978; Graf et al., in press; Graf et at.,
1979). (1) DLVs induce a leukaemic trans-
formation by blocking the differentiation of
their haemopoietic target cells. (2) The
differentiation block is the consequence of
a competitive inhibition of the viral trans-
forming protein synthesized in large amounts
by a hypothetical homologous but non-
identical cellular differentiation-specific pro-
tein. (3) That a competitive inhibition of
transforming protein is only possible in those
cells expressing the putative cellular counter-
part protein (e.g. AEV p75 in erythroblasts
and MC29 plIO in immature macrophages)
explains the target-cell specificity of DLVs.
We are currently trying to test our hypo-
thesis by searching for the postulated cellular
counterpart proteins of the transforming
proteins of DLVs, and to study their tissue
distribution.
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EARLY CARCINOGENESIS, DIFFERENTIATION AND PROMOTION
R. M. HICKS
From the School ofPathology, Middlesex Hospital Medical School, London WI
THE NORMALmammalian urinary bladderis
lined by highly differentiated epithelium
known as the urothelium, which has been
described and illustrated in detail (Hicks,
1975; Hicks et al., 1974; Severs & Hicks,
1977). The markers for normal differen-
tiation include development of highly
specialized, polyploid surface cells, with a
uniquely structured surface membrane. This
particular form oftransitional-cell differentia-
tion is in a state of balance which is very
easilydisturbed. Furthermore, theurothelium
is a multipotential tissue (Hicks, 1975) and
has the option of other forms of differentia-
tion. Thus, if subjected to regular irritation
45*
as from a bladder calculus, the normal
differentiation is disturbed and switches from
transitional-cell differentiation to epider-
malization with the synthesis ofgross keratin
plaques. Similarly, epidermalization is also
produced if the animal is made vitamin A-
deficient, when again the genome for normal
transitional differentiation is apparently
switched off, and that for differentiation to
squamous metaplasia is switched on or ampli-
fied (Hicks, 1968, 1969, 1975, 1976). The
frequency with which epidermalization or
squamous metaplasia of the urothelium is
seen suggests that the genome responsible for
keratinization, though normally repressed,BRITISH ASSOCIATION FOR CANCER RESEARCH
must be readily accessible and easily de-
repressed. An alternative type of differentia-
tion which is also seen in the urothelium is
mucous metaplasia, and this frequently
develops in mild pathological conditions (e.g.
chronic cystitis). Again, this form of differen-
tiation is seensufficientlyfrequently tosuggest
that the area of the genome concerned with
mucous production, though normally re-
pressed, is in a position or state where it is
readily inducible. These 3 forms ofdifferentia-
tion in the normal adult mammalian uro-
thelium all differ morphologically from the
more primitive differentiation of the urothe-
lium seen in the foetus (Firth & Hicks, 1970).
These gross manifestations of differentiation
observed in the normal or nearly normal
urothelium must represent minor variations
at the level of transcription in the control of
the genome in the normal urothelial cell.
Biogenesis of urothelial cancer, though it
occasionally occurs as a result of exposure to
a high dose of a complete carcinogen, is more
usually the outcome of a multi-stage process
of initiation, promotion and propagation
(Hicks et al., 1978; Hicks & Chowaniec, 1978).
In this sequence ofevents the initiator, which
in man is probably a small amount of the
activated form of a urine-borne chemical
carcinogen, reacts with and produces some
permanent alteration to the DNA so that the
DNA carries abnormal information. It has
been shown by Yuspa et al. (1969) that
initiators do not preferentially react with
replicating rather than non-replicating DNA
and therefore, since most of the genes are in
a repressed state, the modified areas of DNA
are more likely to be in an unexpressed rather
than in a transcribing area ofthe genome. No
difference in phenotypic expression will
therefore necessarily be seen in the urothelial
cells after an initiating event. However, the
initiating event is relatively permanent, and
will leave some cells harbouring misinforma-
tion even though they are phenotypically
identical to their unaffected neighbours, as
judged by their functional proteins and
membrane structure. After the initiating
event, although the cell may carry altered
information, so long as the altered area
remains unexpressed no change in phenotype
will occur even when the cell divides in the
normal course of events. Before a change in
phenotype can be seen, a promoting event is
required which will allow the altered area of
genome to become inducible, i.e. the affected
area must be morphologically altered into a
transcribing rather than a non-transcribing
form.
The action of promoters in carcinogenesis
has been extensively studied in the skin, and
we have extended some observations to the
urinary bladder. In general, promoters in-
crease the opportunity for abnormal pheno-
typic expression by accelerating the rate of
mitosis; this also helps to propagate the
tumour. In addition, by randomly altering
gene expression, they increase the oppor-
tunity of expressing any altered information
previously introduced into the genome by
exposure to an initiator. Furthermore, by
inhibiting terminal differentiation of the
tissue, they increase the time required before a
cell will pass into the "differentiate and die"
pathway, and retain the cells for longer in the
cell cycle where they can grow and divide. In
the biogenesis of bladder cancer, vitamin A
deficiency clearly acts asapromotingstimulus.
Vitamin A deficiency causes an increase in
DNA synthesis and increased mitotic activity
in the basal cells of the urothelium which
causes hyperplasia. Coincidentally with this
rather nonspecific stimulation of cell division
and tumour promotion, vitamin A deficiency
also specifically affects the genes controlling
the differentiation of the cell, so that bladder
tumours in vitamin A-deficient animals are
also heavily keratinized. The same is true
where cancer growth is associated with
mechanical irritation, as in the presence of a
urinary calculus or in bilharzial bladder in
which the wall is filled with calcified ova, for
irritation predisposes to squamous meta-
plasia. In both these instances, keratiniza-
tion is concomitant with but not an essential
part of the biogenesis of the neoplasms. The
keratinization demonstrates that vitamin A
deficiency or irritation produce a disturbance
in the normal control oftranscription. If such
factors also encourage random transcription
of the genome, they will automatically in-
crease the chance of transcribing potentially
carcinogenic changes inthegenomeintroduced
by previous exposure to an initiator. We have
demonstrated that saccharin also acts as a
promoter of the growth of bladder cancer in
animals previously subjected to an initiating
dose of the carcinogen methyl nitrosourea
(MNU) (Hicks etal., 1975; Hicks &Chowaniec,
1977). These observations have now been
confirmed by Friedell and his co-workers,
using an initiating dose of another bladder
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carcinogen, the nitrofuran FANFT (Cohen
et al., 1978). It is not known how saccharin
acts as a promoter, but undoubtedly tumours
promoted by saccharin show a wide variety
of differentiation patterns both within the
tumour and in adjacent, non-neoplastic areas
of the urothelium. This suggests that sac-
charin in some way disturbs the normal
control of differentiation and, like vitamin A
deficiency, encourages random gene trans-
cription, thus increasing the chance of
expression of any neoplastic modification of
the growth-controlling genes introduced by
pre-treatment with an initiator. Saccharin
also causes urothelial hyperplasia in some but
not all animals, and increased numbers ofcells
enter mitosis. Thus saccharin has two
properties characteristic of skin promoters:
it appears to increase the chance of random
transcription of the genome and at the same
time it encourages cell division, thus promot-
ing and propagating tumour growth.
The final result ofneoplastic transformation
in any tissue is an altered phenotype, such
that the cancer cell expresses certain proper-
ties which differ from those of normal cells
from which they were derived. It appears to
be a disease in which some concomitant
phenotypic change in differentiation is obliga-
tory. However, the changes which occur in
a tissue during carcinogenesis may also
illustrate many changes in differentiation
which are not necessarily a part of the neo-
plastic growth syndrome. Promoters encour-
age random gene expression and the produc-
tion of multiple phenotypes, among which
may be the phenotype associated with cancer
growth if the tissue has previously been
exposed to an initiating carcinogen.
This work has been supported over a number of
years by generous grants from the Cancer Research
Campaign.
REFERENCES
COHEN, S. M., ARAI, M., JACOBS, J. B. & FRIEDELL,
G. H. (1978) Cancer Res., 39, 1207.
FIRTH, J. A. & HICKS, R. M. (1970) J. Anat., 107,
192.
HICKS, R. M. (1968) J. Ultrastruct. Res., 22, 206.
HICKS, R. M. (1969) J. Anat., 104, 327.
HICKS, R. M. (1975) Biol. Rev., 50, 215.
HICKS, R. M. (1976) Progress in Differentiation
Research. Amsterdam: North Holland Pub. Co.
p. 339.
HICKS, R. M. & CHOWANIEC, J. (1977) Cancer Res.,
37, 2943.
HICKS, R. M. & CHOWANIEC, J. (1978) Int. Rev. Exp.
Pathol., 18, 199.
HICKS, R. M., CHOWANIEC, J. & WAKEFIELD, J.
ST J. (1978) Carcinogenesis, Vol. 2, Mechanisms of
Tumour Promotion and Co-carcinogenesis. New
York: Raven Press. p. 475.
HICKS, R. M., KETTERER, B. & WARREN, R. C. (1974)
Phil. Trans. R. Soc. Lond. B., 268, 23.
HICKS, R. M., WAKEFIELD, J. ST J. & CHOWANIEC, J.
(1975) Chem.-Biol. Interactions, 11, 225.
SEVERS, N. J. & HICKS, R. M. (1977) J. Microscop.,
111, 125.
YUSPA, S. H., DEL SOL, A. E., MORGAN, D. L. &
BATES, R. R. (1969) Chem.-Biol. Interactions, 1,
223.
PROPERTIES OF SARCOMA GROWTH FACTOR AND OTHER PEPTIDE
HORMONES PRODUCED BY MOUSE AND HUMAN TUMOUR CELLS
G. J. TODARO AND J. E. DE LARCO
From the Laboratory of Viral Carcinogenesis, National Cancer Institute, National Institute of
Health, Bethesda, Md., U.S.A.
MOUSE 3T3 cells have been transformed in
culture by a varietyofagents, includingDNA-
containing viruses (SV40, polyoma), RNA-
containing viruses (e.g. MSV, avian sarcoma
viruses) as well as by various chemical
carcinogens and radiation. Ofthese, the clones
transformed by MSV specifically demonstrate
a loss of cell-surface epidermal growth factor
(EGF) receptors. The basis for this apparent
loss ofreceptors is shown to be the production
by the MSV-transformed cells of a low-mol.-
wt peptide (9-IIK) related to EGF. This
sarcoma growth factor (SGF) stimulates
normal fibroblasts to assume a "transformed"
morphology in monolayer cultures and to
form progressively growing colonies in soft
agar. EGF, under similar conditions, stimu-
lates cell division in monolayer cultures but
not anchorage-independent growth in semi-
solid medium.
SGF has been purified from serum-free
medium of MSV-transformed 3T3 cells. A
critical step in the purification involves the
use of formalin-fixed human carcinoma cells,
designated A431, thathave exceptionally high
levels of EGF receptors (2-2 x 106 receptors/